Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users

Obstetrics and Gynecology

Volumn 114, Issue 2, 2009, Pages 279-284

  Le, Yen Chi L ^a   Rahman, Mahbubur ^a   Berenson, Abbey B ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTRACEPTION; CONTROLLED STUDY; FEMALE; HUMAN; INCREASED APPETITE; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; ADULT; APPETITE; BODY MASS INDEX; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; PARITY; PREGNANCY; REGRESSION ANALYSIS; WEIGHT GAIN;

EID: 68949136625     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181af68b2     Document Type: Article

References (19)

1. Bahamondes L, Del CS, Tabares G, Arce XE, Perrotti M, Petta C. Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years. Contraception 2001;64:223-5.
2. Berenson AB, Rahman M. Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. Am J Obstet Gynecol 2009;200:329.e1-8.
3. Bonny AE, Ziegler J, Harvey R, Debanne SM, Secic M, Cromer BA. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med 2006;160:40-5.
4. Espey E, Steinhart J, Ogburn T, Qualls C. Depo-provera associated with weight gain in Navajo women. Contraception 2000;62:55-8.
5. Risser WL, Gefter LR, Barratt MS, Risser JM. Weight change in adolescents who used hormonal contraception. J Adolesc Health 1999;24:433-6.
6. Templeman CL, Cook V, Goldsmith LJ, Powell J, Hertweck SP. Postpartum contraceptive use among adolescent mothers. Obstet Gynecol 2000;95:770-6.
7. Leiman G. Depo-medroxyprogesterone acetate as a contraceptive agent: its effect on weight and blood pressure. Am J Obstet Gynecol 1972;114:97-102.
8. Berenson AB, Rahman M, Breitkopf CR, Bi LX. Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density. Obstet Gynecol 2008;112:788-99.
9. Hosmer DW Jr, Lemeshow S. Applied logistic regression. 2nd ed. New York (NY): John Wiley & Sons, Inc.; 2000.
10. Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation. Contraception 2006;74:90-9.
11. Schwallie PC, Assenzo JR. Contraceptive use-efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fertil Steril 1973;24:331-9.
12. Mangan SA, Larsen PG, Hudson S. Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 2002;15:79-82.
13. Weng HH, Bastian LA, Taylor DH Jr, Moser BK, Ostbye T. Number of children associated with obesity in middle-aged women and men: results from the health and retirement study. J Womens Health (Larchmt ) 2004;13:85-91.
14. Linne Y, Dye L, Barkeling B, Rossner S. Long-term weight development in women: a 15-year follow-up of the effects of pregnancy. Obes Res 2004;12:1166-78.
15. Rooney BL, Schauberger CW, Mathiason MA. Impact of perinatal weight change on long-term obesity and obesity-related illnesses. Obstet Gynecol 2005;106:1349-56.
16. Bonny AE, Britto MT, Huang B, Succop P, Slap GB. Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA). J Pediatr Adolesc Gynecol 2004;17:109-15.
17. Stunkard A, Messick S. The Three-Factor Eating Questionnaire to measure dietary restraint, disinihibition, and hunger. J Psychosom Res 1985;29:71-8.
18. Guthrie GP Jr, John WJ. The in vivo glucocorticoid and antiglucocorticoid actions of medroxyprogesterone acetate. Endocrinology 1980;107:1393-6.
19. Fahmy K, bdel-Razik M, Shaaraway M, al-Kholy G, Saad S, Wagdi A, et al. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile. Contraception 1991;44:419-30.